Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Palisade Bio, Inc. (PALI) vs Q32 Bio Inc. (QTTB)

Palisade Bio, Inc. and Q32 Bio Inc. are both Biotechnology companies. Palisade Bio, Inc. and Q32 Bio Inc. are of similar size ($282.8M and $273.6M). Palisade Bio, Inc. trades at the lower P/E: 2.2× against 2.9×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against −307.3%. Q32 Bio Inc. has the higher net margin (0.00% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Q32 Bio Inc. leads on 11 and Palisade Bio, Inc. on 5.

Valuation

Metric PALI QTTB Biotechnology median
P/E 2.24 2.90 7.88
P/S 405.97 n/m 11.47
P/B 2.52 1.68 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 240.84 (12.07) 10.73
Earnings yield 44.66% 34.44% (28.84%)
Free cash flow yield (5.94%) (7.23%) (23.03%)

Profitability

Metric PALI QTTB Biotechnology median
Gross margin 95.63% 100.00% 65.16%
Operating margin (4,681.99%) 0.00% 0.00%
Net margin (4,230.60%) 0.00% 0.00%
Free cash flow margin (2,409.27%) 0.00% 0.00%
Return on equity (51.37%) 72.14% (57.72%)
Return on assets (47.68%) 37.13% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PALI QTTB Biotechnology median
Revenue growth (TTM) 5,492.59% (307.33%) 5.64%
EPS growth (last fiscal year) 97.06% 148.96% —
Revenue growth, 5-year CAGR 72.86% 100.32% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PALI QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.26 20.30 4.73
Net debt to EBITDA 7.37 (2.21) 0.96

Dividend

Metric PALI QTTB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PALI QTTB Biotechnology median
Market cap 273.60m 282.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack